Segment Data (Tables)

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following tables reflect our segment and Corporate information and reconciles Adjusted EBITDA for reportable segments to consolidated Net income (loss) attributable to Covetrus:

	At and For the Three Months Ended June 30, 2020
	North America		Europe		APAC & Emerging Markets		Corporate		Eliminations		Total
Net sales	$	602	$	342	$	85	$	—	$	(3)	$	1,026
Adjusted EBITDA	$	55	$	16	$	5	$	(13)	$	—	$	63
Total assets	$	3,066	$	635	$	132	$	1,145	$	(1,452)	$	3,526
Reconciliation of net income Attributable to Covetrus to Adjusted EBITDA:
Net income attributable to Covetrus											$	54
Plus: Depreciation and amortization											41
Plus: Interest expense, net											13
Plus: Income tax expense											6
Earnings before interest, taxes, depreciation, and amortization											114
Plus: Share-based compensation											10
Plus: Strategic consulting											5
Plus: Separation programs and executive severance											1
Plus: Formation of Covetrus (a)											7
Plus: Capital structure											1
Less: Other income items, net (b)											(75)
Adjusted EBITDA											$	63
(a) Includes professional and consulting fees, duplicative costs associated with transition service agreements, and other costs incurred in connection with the separation from Former Parent and establishing Covetrus as an independent public company.
(b) Includes a $73 million gain on the divestiture of scil and a $1 million gain on the deconsolidation of SAHS. See Note 3 - Divestiture and Equity Method Investment.

	At and For the Three Months Ended June 30, 2019
	North America		Europe		APAC & Emerging Markets		Corporate		Eliminations		Total
Net sales	$	552	$	370	$	90	$	—	$	(3)	$	1,009
Adjusted EBITDA	$	43	$	19	$	4	$	(13)	$	—	$	53
Total assets	$	3,265	$	797	$	191	$	872	$	(935)	$	4,190
Reconciliation of net loss Attributable to Covetrus to Adjusted EBITDA:
Net loss attributable to Covetrus											$	(10)
Plus: Depreciation and amortization											41
Plus: Interest expense, net											14
Plus: Income tax expense											5
Earnings before interest, taxes, depreciation, and amortization											50
Plus: Share-based compensation											10
Plus: Formation of Covetrus (a)											6
Plus: IT infrastructure											2
Less: Other income items, net											(15)
Adjusted EBITDA											$	53
(a) Includes professional and consulting fees, duplicative costs associated with transition service agreements, and other costs incurred in connection with the separation from Former Parent and establishing Covetrus as an independent public company.

	For the Six Months Ended June 30, 2020
	North America		Europe		APAC & Emerging Markets		Corporate		Eliminations		Total
Net sales	$	1,152	$	764	$	180	$	—	$	(5)	$	2,091
Adjusted EBITDA	$	96	$	34	$	12	$	(31)	$	—	$	111
Reconciliation of net income Attributable to Covetrus to Adjusted EBITDA:
Net income attributable to Covetrus											$	20
Plus: Depreciation and amortization											82
Plus: Interest expense, net											27
Plus: Income tax expense											4
Earnings before interest, taxes, depreciation, and amortization											133
Plus: Share-based compensation											19
Plus: Strategic consulting											9
Plus: Transaction costs (a)											6
Plus: Separation programs and executive severance											2
Plus: IT infrastructure											2
Plus: Formation of Covetrus (b)											14
Plus: Capital structure											1
Less: Other income items, net (c)											(75)
Adjusted EBITDA											$	111
(a) Includes legal, accounting, tax, and other professional fees incurred in connection with acquisitions and divestitures.
(b) Includes professional and consulting fees, duplicative costs associated with transition service agreements, and other costs incurred in connection with the separation from Former Parent and establishing Covetrus as an independent public company.
(c) Includes a $73 million gain on the divestiture of scil and a $1 million gain on the deconsolidation of SAHS. See Note 3 - Divestiture and Equity Method Investment.

	For the Six Months Ended June 30, 2019
	North America		Europe		APAC & Emerging Markets		Corporate		Eliminations		Total
Net sales	$	1,049	$	731	$	176	$	—	$	(6)	$	1,950
Adjusted EBITDA	$	78	$	35	$	8	$	(16)	$	—	$	105
Reconciliation of net loss Attributable to Covetrus to Adjusted EBITDA:
Net loss attributable to Covetrus											$	(23)
Plus: Depreciation and amortization											71
Plus: Interest expense, net											25
Plus: Income tax expense											1
Earnings before interest, taxes, depreciation, and amortization											74
Plus: Share-based compensation											25
Plus: Formation of Covetrus (a)											14
Plus: Carve-out operating expenses											5
Plus: IT infrastructure											2
Less: Other income items, net											(15)
Adjusted EBITDA											$	105
(a) Includes professional and consulting fees, duplicative costs associated with transition service agreements, and other costs incurred in connection with the separation from Former Parent and establishing Covetrus as an independent public company.

See Note 4 - Revenue from Contracts with Customers for our revenue disaggregated by major product category and reportable segment.